FINWIRES · TerminalLIVE
FINWIRES

GCIがアラスカの光ファイバーネットワーク拡張のため、クインティリオンを3億1000万ドルで買収

-- GCIリバティ(GLIBA、GLIBK)傘下のGCIホールディングスとグレイン・マネジメントは水曜日、GCIがアラスカ州の光ファイバーインフラプロバイダーであるQゲートウェイ・インターミディエイト(Quintillion)を買収する契約を締結したと発表した。 両社によると、この買収によりGCIはQuintillionを完全子会社化し、両社の光ファイバーネットワークを統合することで、アラスカ全域における信頼性の高い接続性を向上させるという。 買収額は3億1000万ドルで、通常の運転資金調整などの条件が適用される。GCIはまた、ノーム~ホーマー・エクスプレス・プロジェクトに関連する建設費用のうち、最大5000万ドルを払い戻す。特定の財務目標が達成された場合、2028年、2029年、2031年にも追加の支払いが行われる可能性がある。両社によると、契約締結後まもなく、GCIはQuintillionに対し1億6000万ドルの無担保融資を提供する予定だ。 声明によると、この取引は規制当局の承認と特定の条件の充足後に完了する予定だという。

Price: $37.07, Change: $+0.31, Percent Change: +0.86%

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL